Close Menu

NEW YORK – A clinical research study recently launched by researchers at Weill Cornell Medicine, New York Presbyterian, and the New York Genome Center, with support from Illumina, aims to determine the diagnostic value of clinical whole-genome sequencing in a variety of disease types.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new study finds that farmed fish have led to a decline in genetic diversity among Atlantic salmon, the Guardian reports.

According to Agence France Presse, astronauts who are to arrive soon at the International Space Station are to study the effect of microgravity on brain organoids.

In Cell this week: analysis of SARS-CoV-2 B.1.1.7 introductions to the US, increased horizontal gene transfer higher in gut microbiomes linked to industrialization, and more.

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Apr
22
Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
23
Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.